![Randall Moreadith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Randall Moreadith
Vorstandsvorsitzender bei
Serina Therapeutics (AL), Inc.
Vermögen: - $ am 31.08.2026
Profil
Randall W.
Moreadith was the founder of Oxurion NV, founded in 1996, where the titles held included President & Chief Operating Officer from 1996 to 2003.
Current jobs include President, Chief Executive Officer & Director at Serina Therapeutics (AL), Inc. since 2010; President, Chief Executive Officer & Director at Canaria Therapeutics, Inc.; and Chief Development Officer at Serina Therapeutics, Inc. since 2024.
Former jobs include Chief Medical Officer at Renovis, Inc. from 2004 to 2005; Principal Medical Officer at Quintiles, Inc. (California) from 1996 to 1997; Chief Medical Officer at Tissue Repair Co. from 2006 to 2007; Chief Medical Officer at Post-Hypothermia Corp.; Chief Medical Officer & Executive Vice President at Gene Biotherapeutics, Inc. from 2006 to 2008; and Chief Development Officer & SVP-Drug Development at Nektar Therapeutics in 2009.
Education includes doctorate degrees from Duke University and The Johns Hopkins University, and an undergraduate degree from North Carolina State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 21.05.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
Aktive Positionen von Randall Moreadith
| Unternehmen | Position | Beginn |
|---|---|---|
Serina Therapeutics (AL), Inc.
 Serina Therapeutics (AL), Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies to treat neurological diseases and pain | Vorstandsvorsitzender | 01.09.2010 |
Canaria Therapeutics, Inc.
 Canaria Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches, develops and manufactures medical cannabis & cannabinoid treatments | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Randall Moreadith
| Unternehmen | Position | Ende |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01.12.2009 |
Taxus Cardium Pharmaceuticals Group, Inc.
 Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 |
Tissue Repair Co.
 Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2007 |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 16.12.2005 |
| OXURION NV | Gründer | 01.01.2003 |
Ausbildung von Randall Moreadith
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
39
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Tissue Repair Co.
Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
 North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Post-Hypothermia Corp.
 Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Manufactures and markets temperature modulation therapy devices | Health Technology |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
Oxurion NV
 Oxurion NV Pharmaceuticals: MajorHealth Technology Develops innovative vascular biopharmaceuticals for the treatment of eye disease, vascular disease and cancer | Health Technology |
Serina Therapeutics (AL), Inc.
Serina Therapeutics (AL), Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies to treat neurological diseases and pain | Commercial Services |
Canaria Therapeutics, Inc.
Canaria Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches, develops and manufactures medical cannabis & cannabinoid treatments | Health Technology |
